Ledipasvir/Sofosbuvir Eradicates Hepatitis C in an Immunodeficient STAT3-GOF Patient

Detalles Bibliográficos
Autores principales: Thalhammer, Julian, Maccari, Maria Elena, Wegehaupt, Oliver, Ehl, Stephan, Speckmann, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Letter to Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310846/
https://www.ncbi.nlm.nih.gov/pubmed/33782882
http://dx.doi.org/10.1007/s10875-021-01011-9
_version_ 1783728843308138496
author Thalhammer, Julian
Maccari, Maria Elena
Wegehaupt, Oliver
Ehl, Stephan
Speckmann, Carsten
author_facet Thalhammer, Julian
Maccari, Maria Elena
Wegehaupt, Oliver
Ehl, Stephan
Speckmann, Carsten
author_sort Thalhammer, Julian
collection PubMed
description
format Online
Article
Text
id pubmed-8310846
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-83108462021-08-12 Ledipasvir/Sofosbuvir Eradicates Hepatitis C in an Immunodeficient STAT3-GOF Patient Thalhammer, Julian Maccari, Maria Elena Wegehaupt, Oliver Ehl, Stephan Speckmann, Carsten J Clin Immunol Letter to Editor Springer US 2021-03-29 2021 /pmc/articles/PMC8310846/ /pubmed/33782882 http://dx.doi.org/10.1007/s10875-021-01011-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter to Editor
Thalhammer, Julian
Maccari, Maria Elena
Wegehaupt, Oliver
Ehl, Stephan
Speckmann, Carsten
Ledipasvir/Sofosbuvir Eradicates Hepatitis C in an Immunodeficient STAT3-GOF Patient
title Ledipasvir/Sofosbuvir Eradicates Hepatitis C in an Immunodeficient STAT3-GOF Patient
title_full Ledipasvir/Sofosbuvir Eradicates Hepatitis C in an Immunodeficient STAT3-GOF Patient
title_fullStr Ledipasvir/Sofosbuvir Eradicates Hepatitis C in an Immunodeficient STAT3-GOF Patient
title_full_unstemmed Ledipasvir/Sofosbuvir Eradicates Hepatitis C in an Immunodeficient STAT3-GOF Patient
title_short Ledipasvir/Sofosbuvir Eradicates Hepatitis C in an Immunodeficient STAT3-GOF Patient
title_sort ledipasvir/sofosbuvir eradicates hepatitis c in an immunodeficient stat3-gof patient
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310846/
https://www.ncbi.nlm.nih.gov/pubmed/33782882
http://dx.doi.org/10.1007/s10875-021-01011-9
work_keys_str_mv AT thalhammerjulian ledipasvirsofosbuvireradicateshepatitiscinanimmunodeficientstat3gofpatient
AT maccarimariaelena ledipasvirsofosbuvireradicateshepatitiscinanimmunodeficientstat3gofpatient
AT wegehauptoliver ledipasvirsofosbuvireradicateshepatitiscinanimmunodeficientstat3gofpatient
AT ehlstephan ledipasvirsofosbuvireradicateshepatitiscinanimmunodeficientstat3gofpatient
AT speckmanncarsten ledipasvirsofosbuvireradicateshepatitiscinanimmunodeficientstat3gofpatient

Ejemplares similares